Contribution of [18F]DPA-714 PET for Grading and Exploration of the Inflammatory Microenvironment of Glioma.
NCT05672082
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Organisational difficulties
Conditions
Glioma
Interventions
DRUG:
[18F]DPA-714
Sponsor
Center Eugene Marquis